GAS6 and breast carcinoma: Gas6 high patients with luminal A breast cancer showed significantly improved RFS over Gas6 low patients (n = 1933, p = 1.8 × 10−6) (Fig. 4b), whereas all other subtypes showed only moderate improvement to no change in RFS (Supplementary Fig. 5b).